Top

Journal of Cancer Research and Clinical Oncology

Published in:

01-06-2005 | Original Paper

Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma

Authors: Ratnesh Kumar Singh, Santanu Dasgupta, Nilanjana Bhattacharya, Neelanjana Chunder, Ranjit Mondal, Anup Roy, Syamsundar Mandal, Susanta Roychowdhury, Chinmay Kumar Panda

Published in: Journal of Cancer Research and Clinical Oncology | Issue 6/2005

Abstract

Purpose

The aim of this study was to understand whether there is any association between specific deleted regions in chromosome 11 (chr.11) and alteration (amplification/rearrangement) of Bcl-1/Cyclin D1 locus, located at 11q13, in uterine cervical carcinoma (CA-CX).

Methods

The deletion mapping of chr.11 was studied using 17 highly polymorphic microsatellite markers in 65 primary uterine cervical lesions. The Bcl-1/Cyclin D1 alterations were analyzed by Southern blot and/or polymerase chain reaction (PCR) method in respective cervical lesions.

Results

Chr.11 deletion was found to be significantly associated with progression of CA-CX. High frequency (48–65%) of deletion was found in 11p15.5 (D1), 11q22.3–23.1(D2), and 11q23.3–24.1(D3) regions and significant association was seen among deletions in D2 and D3 regions. Bcl-1/Cyclin D1 locus alteration was observed in overall 27% cervical lesions. Co-amplification of Bcl-1/Cyclin D1 locus was seen in 10% samples. However, no association was found between the deleted regions and Bcl-1/Cyclin D1 locus alterations.

Conclusions

Our study suggests that there is no co-operativity between the deleted regions (D1- D3) in chr.11 and Bcl-1/Cyclin D1 alterations, but these alterations may provide cumulative effect in progression of the tumor. The D1–D3 regions may harbor candidate tumor suppressor gene(s) (TSGs) associated with the development of CA-CX.

Akiyama N, Tsuruta H, Sasaki H, Sakamoto H, Hamaguchi M, Ohmura Y, Seto M, Ueda R, Hirai H, Yazaki Y, Sugimura T, Terada M (1994) Messenger RNA levels of five genes located at chromosome 11q13 in B cell tumors with chromosome translocation t(11;14) (q13;q32). Cancer Res 54:377–379

Arai Y, Hosoda F, Kobayashi H, Arai K, Hayashi Y, Kamada N, Kaneko Y, Ohki M (1997) The inv (11) (p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10. Blood 89:3936–3944

Azzena A, Zen T, Ferrara A, Brunetti V, Vasile C, Marchetti M (1994) Risk factors for breast cancer. Case-control study results. Eur J Gynecol Oncol 15:386–392

Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU, Chan SY (1995) Human papillomavirus in 91 oral cancers from Indian betel quid chewers—high prevalence and multiplicity of infections. Int J Cancer 61:450–454

Berenson JR, Yang J, Mickel RA (1989) Frequent amplification of the Bcl-1 locus in head and neck squamous cell carcinoma. Oncogene 4:1111–1116

Cattani P, Hohaus S, Bellacosa A, Genuardi M, Cavallo S, Rovella V, Almadori G, Cadoni G, Galli J, Maurizi M, Fadda G, Neri G (1998) Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma. Clin Cancer Res 4:2585–2589

Cheung TH, Yu MMY, Lo KWK, Yim SF, Chung TKH, Wong YF (2001) Alteration of Cyclin D1 and CDK4 gene in carcinoma of uterine cervix. Cancer Lett 166:199–206

Chunder N, Mandal S, Roy A, Roychoudhury S, Panda CK (2004) Analysis of different deleted regions in chromosome 11 and their interrelations in early and late-onset breast tumors: association with Cyclin D1 amplification and survival. Diagn Mol Pathol 13:172–182

Dasgupta S, Mukherjee N, Roy S, Roy A, Roychowdhury S, Panda CK (2002) Mapping of the candidate tumor suppressor gene’s loci on human chromosome 3 in head and neck squamous cell carcinoma of Indian patient population. Oral Oncol 38:6–15

Dasgupta S, Chakraborty SB, Roy A, Roychowdhury S, Panda CK (2003) Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients. Mol Pathol 56:263–269

D’ Costa J, Saranath D, Dedhia P, Sanghvi V, Mehta AR (1998) Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 34:413–420

Donnellan R, Chetty R (1998) Cyclin D1 and human neoplasia. Mol Pathol 51:1–7

Gentile M, Ahnstrom M, Schon F, Wingren S (2001) Candidate tumor suppressor genes at 11q23–24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53 -induced apoptosis. Oncogene 20:7753–7760

Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, Busby-Earle RMC, Williams AWR, Steel CM, Bird CC, Stanbridge EJ, Evans GA (1994) Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor suppressor gene to chromosome 11q22–24. Proc Natl Acad Sci USA 9:6953–6957

Hampton GM, Larson AA, Baergen RN, Sommers RL, Kern S, Cavenee WK (1996) Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi- automated fluorescence based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc Natl Acad Sci USA 93:6704–6709

Hu RJ, Lee MP, Connors TD, Johnson LA, Burn TC, Su K, Landes GM, Feinberg AP (1997) A 2.5- Mb transcript map of a tumor suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genes. Genomics 46:9–17

Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G (1994) PRAD-1/Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54:4813–4817PubMed

Jesudasan RA, Rahman RA, Chandrasherakharappa S, Evans GA, Srivatsan ES (1995) Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines. Am J Hum Genet 56:705–715

Koi M, Morita H, Yamada H, Satoh H, Barrett JC, Oshimura M (1989) Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa. Mol Carcinog 2:12–21

Krissansen GW, Owen MJ, Verbi M, Crumpton MJ (1986) Primary structure of the T3 γ subunit of the T3/T cell antigen receptor complex deduced from cDNA sequences: evolution of the T3 γ and δ subunits. EMBO J 8:1799–1808

Kurzrock R, Ku S, Talpaz M (1995) Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) Oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. Cancer 75:584–590

Kyomoto R, Kumazawa H, Toda Y, Sakaida N, Okamura A, Iwanaga M, Shintaku M, Yamashita T, Hiai H, Fukumoto M (1997) Cyclin -D1-Gene amplification is a more potent prognostic factor than its protein overexpression in human head and neck squamous cell carcinoma. Int J Cancer 74:576–581

Lazo PA (1999) The molecular genetics of cervical carcinoma. Br J Cancer 80:2008–2018

Martin ES, Rossano C, Pentimalli F, Yoder K, Fishel R, Himelstein AL, Martin SE, Godwin AK, Negrin M, Croce CM (2003) The BCSC-1 locus at chromosome 11q23–24 is a candidate tumor suppressor gene. Proc Natl Acad Sci USA 100:11517–11522

Milde-Langosch K, Riethdorf S (2003) Role of cell cycle regulatory protein in gynecological cancer. J Cell Physiol 196:224–244

Mitra AB, Murthy VVVS, Pratap M, Sodhani P, Chaganti R (1994) ERBB2 (HER2/neu) Oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix. Cancer Res 54:637–639

Mondal G, Tripathi A, Bhattacharya N, Sikadar N, Roy A, Sengupta A, Roy B, Panda CK, Roychoudhury S (2003) Allelic imbalance at chromosome 11 in head and neck squamous cell carcinoma in an Indian patient population. J Clin Pathol 56:512–518

Munger K, Heselmeyer K (1999) The molecular pathogenesis of cervical cancer: the role of human papillomavirus. In: Srivatsava S et al. (eds) Molecular pathology of early cancer. IOS, pp 97–111

Narayan G, Pulido HA, Koul S, Lu XY, Harris CP, Yeh YA, Vargas H, Posso H, Terry MB, Gissmann L, Schneider A, Mansukhani M, Rao PH, Murty VVVS (2002) Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression. Oncogene 22:3489–3499

Park JS, Dong SM, Kim HS, Lee JY, Um SJ, Park IS, Kim SJ, Namkoong SF (1999) Detection of p16 gene alteration in cervical cancer using tissue microdissection and LOH study. Cancer Lett 136:101–108

Perucca-Lostanlen D, Hecht BK, Courseaux A, Grosgeorge J, Hecht F, Gaudray P (1997) Mapping of FRA11A, a folate- sensitive fragile site in human chromosome band 11q13.3. Cytogenet Cell Genet 79:88–91

Pulido HA, Fakruddin MJ, Chatterjee A, Esplin ED, Beleno N, Martinez G, Posso H, Evans GA, Murty VVVS (2000) Identification of a 6-cM minimal deletion at 11q23.1–23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer. Cancer Res 60:6677–6682

Rabbits PH, Douglas J, Fisher P, Nacheva E, Karpas A, Catovsky D, Melo JV, Baer R, Stinson MA, Rabbits TH (1988) Chromosome abnormalities at 11q13 in B-cell tumors. Oncogene 3:99–103

Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor, NY

Saxon PJ, Srivatsan ES, Stanbridge (1986) Introduction of human chromosome 11 via micro-cell transfer controls tumorigenic expression of HeLa cells. EMBO J 5:3461–3466

Schiffman MH, Brinton LA (1995) The Epidemiology of cervical carcinogenesis. Cancer [Supp] 76:1888–1897

Schuuring E, Verhoeven E, Mooi WJ, Michalides RJAM (1992) Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas Oncogene 7:355–361

Schwab M (1998) Amplification of oncogenes in human cancer cells. Bioessays 20:473–479

Sen U, Sankaranarayanan R, Mandal S, Ramanakumar AV, Parkin DM, Siddiqi M (2002) Cancer patterns in eastern India: the first report of the Kolkata cancer registry. Int J Cancer 100:86–91

Shanta V, Krishnamurthi S, Gajalakshmi CK, Swaminathan R, Ravichandran K (2000) Epidemiology of cancer of the cervix: global and national perspective. J Indian Med Assoc 98:49–52

Shuster MI, Han L, Le Beau MM, Davis E, Sawicki MP, Lese CM, Park NH, Colicelli J, Gollin S (2000) A consistent pattern of RIN 1 rearrangement in oral squamous cell carcinoma cell lines supports a breakage-fusion- bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer 28:153–163

Skomedal H, Helland A, Kristensen GB, Holm R, Dale ALB (1999) Allelic imbalance at chromosome region 11q23 in cervical carcinomas. Eur J Cancer 35:659–663

Smits PH, Smits HL, Jebbink MF, ter Schegget J (1990) The short arm of chromosome 11 likely is involved in the regulation of the human papilloma virus type −16 early enhancer-promoter and in the suppression of the transforming activity of the viral DNA. Virology 176:158–165

Srivatsan ES, Chakrabarti R, Zainabadi K, Pack SD, Benyamini P, Mendonca MS, Yang PK, Kang K, Motamedi D, Sawicki MP, Zhuang Z, Jesudasan RA, Bengtsson U, Sun C, Roe BA, Stanbridge EJ, Wilczynski SP, Redpath JL (2002) Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer. Oncogene 21:5631–5642

Steenbergen RDM, Kramer D, Braakhuis BJM, Stern PL, Verheijen RHM, Meijer CJLM, Snijders PJF (2004) TSLC1 Gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 96:294–305

Tavani A, Negri E, La Vecchia C (1996) Menstrual and reproductive factors and biliary tract cancers. Eur J Cancer Prev 5:241–247

The genome browser gateway (http://genome.ucsc.edu/cgi-bin/hgGateway)

The Genome Database (http://www.gdb.org)

Tripathi A, Banerjee S, Chunder N, Roy A, Sengupta A, Roy B, Roychowdhury S, Panda CK (2003a) Differential alterations of the genes in the CDKN2A- CCND1- CDK4-RB1 pathway are associated with the development of head and neck squamous cell carcinoma in Indian patients. J Cancer Res Clin Oncol 129:642–650

Tripathi A, Banerjee S, Roy A, Roychowdhury S, Panda CK (2003b) Alteration of p16 gene in uterine cervical carcinoma from Indian patients. Int J Gynecol Cancer 13:472–479

Zhang A, Maner S, Betz R, Angstrom T, Stendahl U, Bergman F, Zetterberg A, Wallin K (2002) Genetic alterations in cervical carcinomas: frequent low level amplifications of oncogenes are associated with human papillomavirus infection. Int J Cancer 101:427–433

Zur Hausen H (1996) Papillomavirus infection—major cause of human cancers. Biochem Biophys Acta 1288:55–78

Title: Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma
Authors: Ratnesh Kumar Singh
Santanu Dasgupta
Nilanjana Bhattacharya
Neelanjana Chunder
Ranjit Mondal
Anup Roy
Syamsundar Mandal
Susanta Roychowdhury
Chinmay Kumar Panda
Publication date: 01-06-2005
Publisher: Springer-Verlag
Published in: Journal of Cancer Research and Clinical Oncology / Issue 6/2005
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-004-0655-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2005

The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells

Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications

Increased activity of lysosomal enzymes in the peritoneal fluid of patients with gynecologic cancers and pelvic inflammatory disease

Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity

In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum

Evaluation of glucocorticoid sensitivity in 697 pre-B acute lymphoblastic leukemia cells after overexpression or silencing of MAP kinase phosphatase-1

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials